UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000033647 |
|---|---|
| Receipt number | R000038129 |
| Scientific Title | Trial of a multiplex genomic testing by "Todai OncoPanel" for Geneprofiling of malignant solid tumors |
| Date of disclosure of the study information | 2018/08/10 |
| Last modified on | 2023/08/10 09:27:44 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/08/06 21:25:45 | ||
| 2 | Update | 2018/08/06 21:48:54 | Acronym |
|
| 3 | Update | 2018/08/08 23:39:34 | Name of primary person or sponsor Institute Organization1 Tel1 |
|
| 4 | Update | 2019/03/30 18:48:18 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Interventions/Control_1 |
|
| 5 | Update | 2019/08/07 23:36:55 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Division name Division name Zip code Address3 Tel3 Organization Organization Address Address Tel |
|
| 6 | Update | 2019/08/07 23:44:38 | Anticipated trial start date Last follow-up date Other related information Other related information |
|
| 7 | Update | 2019/08/07 23:47:23 | 1st name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person |
|
| 8 | Update | 2019/08/10 15:17:35 | Key inclusion criteria |
|
| 9 | Update | 2020/02/06 20:18:50 | Recruitment status Date of IRB |
|
| 10 | Update | 2020/08/07 15:22:55 | Number of participants that the trial has enrolled |
|
| 11 | Update | 2023/08/10 09:25:15 | Recruitment status Date of closure to data entry |
|
| 12 | Update | 2023/08/10 09:27:44 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
